Diffuse Pancreatic Carcinoma with Hepatic Metastases

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Diagnostic markers</td><td class="align_center">Carbohydrate antigens, microRNAs, macrophage inhibitory cytokine 1, PAM4 antibodies, glypican, KRAS mutation, osteopontin, epigenetic markers</td></tr><tr><td class="align_left">Predictive biomarkers</td><td class="align_center">Gemcitabine markers, FOLFIRINOX markers, nab-paclitaxel markers, stromal markers, BRCA mutated tumors, microsatellite instability, PD-1/PD-L1</td></tr><tr><td class="align_left">Prognostic markers</td><td class="align_center">CA19-9, SMAD4, angiogenesis markers, inflammatory markers, immune markers, microRNAs, SPARC</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Case Reports in Oncological Medicine

tab1

Table 1

Table 1: Diffuse Pancreatic Carcinoma with Hepatic Metastases 